-+ 0.00%
-+ 0.00%
-+ 0.00%

X4 Pharmaceuticals Executive Chairman Adam R. Craig Reports Acquisition of $11,883.64 in Common Shares

PUBT·10/19/2026 20:08:30
Listen to the news
X4 Pharmaceuticals Executive Chairman Adam R. Craig Reports Acquisition of $11,883.64 in Common Shares
  • X4 Pharmaceuticals Executive Chairman Adam R. Craig purchased 4,600 shares of common stock at $2.5834 each.
  • His direct beneficial ownership rose to 333,251 shares following the purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. X4 Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001339498-26-000005), on October 19, 2026, and is solely responsible for the information contained therein.